Literature DB >> 12079377

The ATP-operated clamp of human DNA topoisomerase IIalpha: hyperstimulation of ATPase by "piggy-back" binding.

Spencer Campbell1, Anthony Maxwell.   

Abstract

We have constructed a series of clones encoding N-terminal fragments of human DNA topoisomerase IIalpha. All fragments exhibit DNA-dependent ATPase activity. Fragment 1-420 shows hyperbolic dependence of ATPase on DNA concentration, whereas fragment 1-453 shows hyperstimulation at low ratios of DNA to enzyme, a phenomenon found previously with the full-length enzyme. The minimum length of DNA found to stimulate the ATPase activity was approximately 10 bp; fragments >or=32 bp manifest the hyperstimulation phenomenon. Molecular mass studies show that fragment 1-453 is a monomer in the absence of nucleotides and a dimer in the presence of nucleotide triphosphate. The results are consistent with the role of the N-terminal domain of topoisomerase II as an ATP-operated clamp that dimerises in the presence of ATP. The hyperstimulation effect can be interpreted in terms of a "piggy-back binding" model for protein-DNA interaction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079377     DOI: 10.1016/S0022-2836(02)00461-8

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide.

Authors:  Tanushri Sengupta; Mandira Mukherjee; Aditi Das; Chhabinath Mandal; Rakhee Das; Tanmoy Mukherjee; Hemanta K Majumder
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

Review 2.  Intronic Polyadenylation in Acquired Cancer Drug Resistance Circumvented by Utilizing CRISPR/Cas9 with Homology-Directed Repair: The Tale of Human DNA Topoisomerase IIα.

Authors:  Terry S Elton; Victor A Hernandez; Jessika Carvajal-Moreno; Xinyi Wang; Deborah Ipinmoroti; Jack C Yalowich
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

3.  Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187.

Authors:  Scott Classen; Stephane Olland; James M Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

4.  Characterisation of the DNA-dependent ATPase activity of human DNA topoisomerase IIbeta: mutation of Ser165 in the ATPase domain reduces the ATPase activity and abolishes the in vivo complementation ability.

Authors:  Katherine L West; Rosalind M Turnbull; Elaine Willmore; Jeremy H Lakey; Caroline A Austin
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

5.  The pentapeptide-repeat protein, MfpA, interacts with mycobacterial DNA gyrase as a DNA T-segment mimic.

Authors:  Lipeng Feng; Julia E A Mundy; Clare E M Stevenson; Lesley A Mitchenall; David M Lawson; Kaixia Mi; Anthony Maxwell
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

6.  Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase II.

Authors:  Tanushri Sengupta; Mandira Mukherjee; Rakhee Das; Aditi Das; Hemanta K Majumder
Journal:  Nucleic Acids Res       Date:  2005-04-28       Impact factor: 16.971

7.  Binding of two DNA molecules by type II topoisomerases for decatenation.

Authors:  Rupesh Kumar; Jane E Riley; Damian Parry; Andrew D Bates; Valakunja Nagaraja
Journal:  Nucleic Acids Res       Date:  2012-09-18       Impact factor: 16.971

8.  Substituted 4,5'-Bithiazoles as Catalytic Inhibitors of Human DNA Topoisomerase IIα.

Authors:  Kaja Bergant Loboda; Matej Janežič; Martina Štampar; Bojana Žegura; Metka Filipič; Andrej Perdih
Journal:  J Chem Inf Model       Date:  2020-06-22       Impact factor: 4.956

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.